Published in Bone Marrow Transplant on May 09, 2011
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation. Haematologica (2012) 1.39
Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant (2013) 0.92
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression. Biol Blood Marrow Transplant (2013) 0.88
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood (2014) 0.86
New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease. Br J Clin Pharmacol (2016) 0.81
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease. Haematologica (2015) 0.80
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II. Clin Pharmacokinet (2016) 0.75
Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. Bone Marrow Transplant (2014) 0.75
Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Transplant (2014) 0.75
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation. Biol Blood Marrow Transplant (2016) 0.75
Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus. Bone Marrow Transplant (2014) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Optimal two-stage designs for phase II clinical trials. Control Clin Trials (1989) 21.03
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood (2006) 3.33
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet (2000) 2.81
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood (2006) 2.21
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood (2008) 2.21
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2005) 2.12
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors. Biol Blood Marrow Transplant (2008) 1.96
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2005) 1.85
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation (2005) 1.75
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood (2008) 1.71
Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2005) 1.70
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS One (2009) 1.69
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings. Bone Marrow Transplant (2005) 1.57
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplant (1998) 1.47
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant (2005) 1.44
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation (2001) 1.41
A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation (2001) 1.41
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 1.30
Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Biol Blood Marrow Transplant (2006) 1.29
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation (2007) 1.28
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood (2005) 1.27
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2005) 1.23
Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med (2006) 1.20
Rapamycin: clinical results and future opportunities. Transplantation (2001) 1.20
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation. Clin Pharmacol Ther (2005) 1.18
Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol (2001) 1.17
Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. Cell Cycle (2007) 1.15
Sirolimus: a comprehensive review. Expert Opin Pharmacother (2001) 1.04
Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Transplantation (1999) 1.02
Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation (2005) 1.00
Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant (2009) 1.00
Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant (2006) 0.99
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2006) 0.93
The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation (2005) 0.89
Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation. J Clin Pharmacol (2007) 0.87
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Biol Blood Marrow Transplant (1997) 0.85
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. Bone Marrow Transplant (2010) 0.85
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation (1998) 0.83
Calcineurin-inhibitor-sparing immunosuppressive protocols. Transplant Proc (2005) 0.81
Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients. Transplant Proc (1999) 0.79
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients. Transplant Proc (2002) 0.79
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (1991) 16.77
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (1998) 5.98
Etiology of human breast cancer: a review. J Natl Cancer Inst (1973) 5.88
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend (1996) 5.35
Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol (1998) 4.52
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol (1990) 4.16
TCP1 complex is a molecular chaperone in tubulin biogenesis. Nature (1992) 3.52
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol (1978) 3.40
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol (1988) 3.18
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation (2000) 3.12
Adaptive licensing: taking the next step in the evolution of drug approval. Clin Pharmacol Ther (2012) 3.08
Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell (1999) 2.92
The patient-centred clinical method. 2. Definition and application. Fam Pract (1986) 2.83
Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet (1996) 2.81
Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol (1993) 2.79
Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry (1999) 2.73
Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 2.60
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59
Cigarette smoking and urinary estrogens. N Engl J Med (1982) 2.55
Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res (1995) 2.47
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
Notch gene expression during pancreatic organogenesis. Mech Dev (2000) 2.36
MEK kinase activity is not necessary for Raf-1 function. EMBO J (2001) 2.36
Effect of sulindac on sporadic colonic polyps. Gastroenterology (1995) 2.27
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Physicians certified in family medicine. What are they doing 8 to 10 years later? Can Fam Physician (2001) 2.21
Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem (2001) 2.20
Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature (1990) 2.20
Infection after total knee arthroplasty. J Bone Joint Surg Br (2004) 2.17
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
The Hamilton scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry (1992) 2.16
Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res (1997) 2.11
Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry (1996) 2.10
Parent-offspring coadaptation and the dual genetic control of maternal care. Science (2001) 2.10
Contemporaneous disequilibrium, a new hypothesis to explain the "paradox of the plankton". Proc Natl Acad Sci U S A (1970) 2.09
Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med (1989) 2.07
Postpartum coma. Lancet (1998) 2.07
Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) (1994) 2.05
The effect of single prenatal and natal complications upon the development of children of mature birthweight. Pediatrics (1969) 2.04
Highly aggressive behaviour of occult papillary thyroid carcinoma. J Laryngol Otol (1995) 2.04
Percutaneous endoscopic gastrostomy: evaluation of insertion by an endoscopy nurse practitioner. Eur J Gastroenterol Hepatol (1996) 2.03
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol (1999) 2.03
Vitamin D3 and brain development. Neuroscience (2003) 2.01
Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America. J Infect Dis (1995) 2.00
Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol (1990) 1.96
Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med (1994) 1.95
Involving South Asian patients in clinical trials. Health Technol Assess (2004) 1.93
The patient-centred clinical method. 3. Changes in residents' performance over two months of training. Fam Pract (1986) 1.93
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study. J Hum Hypertens (2007) 1.91
Hypoglycaemia in African children with severe malaria. Lancet (1987) 1.88
Jejunal microflora in malnourished Gambian children. Arch Dis Child (1975) 1.87
Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain (1992) 1.86
Aniridia-associated cytogenetic rearrangements suggest that a position effect may cause the mutant phenotype. Hum Mol Genet (1995) 1.86
Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med (1995) 1.85
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
Saccharomyces cerevisiae RAI1 (YGL246c) is homologous to human DOM3Z and encodes a protein that binds the nuclear exoribonuclease Rat1p. Mol Cell Biol (2000) 1.82
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80
Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess (1999) 1.80
The validity of instruments measuring tic severity in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry (1992) 1.79
Beta-lactam antibiotic biosynthetic genes have been conserved in clusters in prokaryotes and eukaryotes. EMBO J (1990) 1.78
Child abuse and neglect and the development of mental disorders in the general population. Dev Psychopathol (2001) 1.77
Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office. Patient Educ Couns (1997) 1.76
Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75
Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest (1973) 1.74
Dental practitioners and ill health retirement: a qualitative investigation into the causes and effects. Br Dent J (2010) 1.74
Young children's understanding of other people's feelings and beliefs: individual differences and their antecedents. Child Dev (1991) 1.72
Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum (2004) 1.71
Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain (2003) 1.70
T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature (1985) 1.69
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant (2010) 1.68
Gene transfer in intact animals. Nature (1980) 1.68
Translating the CAHPS 1.0 Survey Instruments into Spanish. Consumer Assessment of Health Plans Study. Med Care (1999) 1.68
Drowning and near-drowning involving children: a five-year total population study from the City and County of Honolulu. Am J Public Health (1979) 1.68
Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate. Emerg Med J (2006) 1.68
Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res (1996) 1.67
In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol Cell Biol (2000) 1.66
Air embolism occurring as a complication of central venous catheterization. Ann Surg (1978) 1.66
Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66
Frequency of optic disc or parapapillary nerve fiber layer drusen in retinitis pigmentosa. Ophthalmology (1997) 1.65
Transforming growth factor-beta1 mediates coexpression of the integrin subunit alphaE and the chymase mouse mast cell protease-1 during the early differentiation of bone marrow-derived mucosal mast cell homologues. Clin Exp Allergy (2002) 1.65
Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess (2005) 1.64
Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Ann Intern Med (1990) 1.64
Identification of the duplicated segments in rice chromosomes 1 and 5 by linkage analysis of cDNA markers of known functions. Theor Appl Genet (1994) 1.63
Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales. Br J Urol (1997) 1.63
Premorbid personality assessments of first onset of major depression. Arch Gen Psychiatry (1989) 1.62
Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive model. Thorax (1996) 1.62
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
Fear and frustration--the Liverpool cholera riots of 1832. Lancet (2001) 1.61
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant (1999) 1.61
Primary structure of the phage P22 repressor and its gene c2. Biochemistry (1981) 1.61